Skip to content

Single Arm Clinical Study To Assess The Efficacy Of Vatari Guggul In Amavata (Rheumatoid Arthritis) With Special Reference To C-Reactive Protein

Single Arm Clinical Study To Assess The Efficacy of Vatari Guggul in Amavata(Rheumatoid Arthritis) With Special Reference To C-rective Protien - Vatari Guggul

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/091435
Enrollment
35
Registered
2025-07-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

Dr Vaibhav Shyam Athawale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient having the signs and symptoms of Amavata as per Ayurveda view like sandhishool (pain at joints), sandhishotha (swelling over joints), sandhi stabhdhata (stiffness over joints), tivra sparshasahatva (tenderness over joints) upto 2 year. 2. The patients of Age group 20 to 60 years will be selected. 3. The patients will be selected irrespective of sex, religion.

Exclusion criteria

Exclusion criteria: 1. the patient of age less than 20yr and greater than 60yr. 2. pregnancy, lactating mother. 3. known case of syphilitis arthritis, Systemic Lupus Erythematosus, psoriatic arthritis

Design outcomes

Primary

MeasureTime frame
To study the effect of vatari guggul on Amavata (Rheumatoid Arthritis) with special reference to C- reactive proteinTimepoint: 30 days

Secondary

MeasureTime frame
1) To study Amavata according to Ayurvedic literature. 2) To study Rheumatoid Arthritis. 3) To study C-Reactive Protein. 4) To study changes in Symptoms of Amavata 5) To study changes in C-Reactive Protein in Amavata by using Vatari GuggulTimepoint: 30 days

Countries

India

Contacts

Public ContactDr Abhimanyu Patil

LRP Ayurvedic medical college and hospital

manyupatil@gmail.com9960538603

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026